Add to ORKGObjectives To quantify the proportion of randomized controlled trials (RCTs) specifically designed for elderly, and to assess their characteristics, as compared to RCTs not specifically designed for elderly
To critically assess the external validity of randomized controlled trials (RCTs) it is important to...
OBJECTIVES: To investigate the inclusion of older people in clinical trials of recently authorized m...
To critically assess the external validity of randomized controlled trials (RCTs) it is important to...
<p>Showing the proportion of trials reporting geriatric assessments in the population descriptives o...
<p>* Data are based on 1240 (91%) trials</p><p>** Data are based on 787 (57%) trials</p><p><sup>1</s...
To quantify the proportion of randomized controlled trials (RCTs) specifically designed for elderly,...
To quantify the proportion of randomized controlled trials (RCTs) specifically designed for elderly,...
<p>General characteristics of registered interventional trials studying exclusively elderly persons....
Background. Very elderly subjects (VES; aged 80 years or older) constitute a special population as t...
<p>Showing the distribution of different geriatric measurements and expressed as percentage of the t...
In conclusion, elderly hospitalised patients form a patient group that is at higher risk for medicat...
Background: We aimed to determine the representation of elderly people in published reports of rando...
<p>Pie chart showing the amount and proportion of randomized controlled trials designed for elderly....
Background: Elderly patients represent the greatest consumers of healthcare per capita but have hist...
<p>(1) Mean age, (2) proportion of subjects aged 65 or older and (3) proportion of subjects aged 75 ...
To critically assess the external validity of randomized controlled trials (RCTs) it is important to...
OBJECTIVES: To investigate the inclusion of older people in clinical trials of recently authorized m...
To critically assess the external validity of randomized controlled trials (RCTs) it is important to...
<p>Showing the proportion of trials reporting geriatric assessments in the population descriptives o...
<p>* Data are based on 1240 (91%) trials</p><p>** Data are based on 787 (57%) trials</p><p><sup>1</s...
To quantify the proportion of randomized controlled trials (RCTs) specifically designed for elderly,...
To quantify the proportion of randomized controlled trials (RCTs) specifically designed for elderly,...
<p>General characteristics of registered interventional trials studying exclusively elderly persons....
Background. Very elderly subjects (VES; aged 80 years or older) constitute a special population as t...
<p>Showing the distribution of different geriatric measurements and expressed as percentage of the t...
In conclusion, elderly hospitalised patients form a patient group that is at higher risk for medicat...
Background: We aimed to determine the representation of elderly people in published reports of rando...
<p>Pie chart showing the amount and proportion of randomized controlled trials designed for elderly....
Background: Elderly patients represent the greatest consumers of healthcare per capita but have hist...
<p>(1) Mean age, (2) proportion of subjects aged 65 or older and (3) proportion of subjects aged 75 ...
To critically assess the external validity of randomized controlled trials (RCTs) it is important to...
OBJECTIVES: To investigate the inclusion of older people in clinical trials of recently authorized m...
To critically assess the external validity of randomized controlled trials (RCTs) it is important to...